GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Vanda Pharmaceuticals Inc. (VNDA) [hlAlert]

Rating:
Overweight
VNDA
up 213.87 %

Vanda Pharmaceuticals Inc. (VNDA) rated Overweight by Piper Jaffray

Posted on: Wednesday,  Nov 27, 2013  8:25 AM ET by Piper Jaffray

Piper Jaffray rated Overweight Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) on 11/27/2013. Previously Piper Jaffray rated Overweight Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) on
03/06/2013., when the stock price was $3.82. Since then, Vanda Pharmaceuticals Inc. has gained 213.87% as of 01/27/2016's recent price of $11.99.
If you would have followed the previous Piper Jaffray's recommendation on VNDA, you would have gained 213.87% of your investment in 1057 days.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics & genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. The Company has three product candidates in clinical development. It's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia & bipolar disorder & is in a Phase III clinical trial for schizophrenia. It's second product candidate, is a compound for the treatment of insomnia & depression which is currently in a Phase III clinical trial for insomnia. It's third product candidate, is a compound for the treatment of excessive sleepiness & is ready for a Phase II clinical trial.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/27/2013 8:25 AM Buy
None
11.65
as of 12/13/2013
1 Week down  -0.09 %
1 Month down  -20.93 %
3 Months down  -11.42 %
1 YTD down  -11.50 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/6/2013 8:25 AM Buy
None
3.82

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy